$SKYH

Gonzalez Francisco purchased $15K of SKYH

Gonzalez Francisco (Chief Financial Officer) purchased 1,600 shares of Sky Harbour Group Corp (SKYH) at $9.40 on 2026-10-01.

Original reporting
SEC EDGAR · Gonzalez Francisco
Published Oct 2, 2026, 1:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 1:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SKYH
Bullish
medium confidence
Mentioned
$SKYH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SKYHBullishLow
01

Why it matters

The filing provides a fresh data point on insider sentiment, but the monetary amount is modest.

02

Market read

Minor insider purchase with limited immediate market impact.

03

What to watch

If the CFO is accumulating ahead of a strategic shift, the signal could be more material than size suggests.

Relevance 4/10Novelty 4/10Timing: today

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the CFO's purchase.

Company-level read

Ticker impact

$SKYHBullishMedium confidence
Context

CFO Gonzalez Francisco bought 1,600 shares for $15,040, increasing his stake to 714,688 shares.

Expected impact

potential slight upward pressure as market absorbs insider buying

Evidence & confidence

The purchase is small relative to market cap, but insider buying is a bullish signal; impact limited by size.

Market effects

None

None

None

Counterpoint

The purchase is too small to move the stock; investors may ignore it.

Key entities

  • Sky Harbour Group Corp

    Issuer of the Form 4 filing.

  • Gonzalez Francisco

    Chief Financial Officer of Sky Harbour Group Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SKYHMed

Sky Harbour Targets EBITDA Inflection as Private Hangar Network Expands

Sky Harbour Group (NYSE:SKYH) expects to achieve EBITDA positivity by year-end, driven by its expanding network of private hangar campuses. The company operates eight campuses and has 23 ground leases, with four under construction. It aims to maintain development costs around $300 per square foot. Sky Harbour's debt includes a 2021 issuance at 4.18% and a 4.73% construction facility with JPMorgan. Lease rates at Miami Opa-locka averaged $41 per square foot in phase one and $51 in phase two.

$SKYHMedAI 8/10

Sky Harbour announces $40 million equity financing deal

Sky Harbour Group (SKYH) entered a stock purchase agreement for a registered direct offering of 4,000,000 Class A common shares at $10.00 each, closing Aug. 12, 2026, for $40 million gross proceeds for general corporate purposes. A 90-day lock-up was agreed. Boston Omaha arranged a concurrent secondary sale of 360,000 shares at $10.00, expected to close Aug. 14, 2026.

$SKYHMed

Sky Harbour Announces Q2 Results and Updates on Leasing, Construction, Funding and Other Activities Reaffirms Guidance for Year End 2026

Sky Harbour Group Corp (SKYH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sky Harbour Announces Q2 Results and Updates on Leasing, Construction, Funding and Other Activities Reaffirms Guidance for Year End 2026 WEST HARRISON, N.Y.--( BUSINESS WIRE )--Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation

$SKYHMedAI 8/10

Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

Skyhawk Therapeutics reported 12-month cUHDRS subcomponent results from its Phase 1/2 trial of oral Huntington’s disease candidate SKY-0515. Mean changes vs expected worsening (from Enroll-HD propensity-weighted analyses) were favorable for TFC (+0.07 vs -0.87), TMS (-2.00 vs 2.21), SDMT (-0.19 vs -1.78), and SWRT (+3.44 vs -3.13). CGI/PGI showed no assessed worsening and 65% of participants/50% of clinicians reported improvement; mHTT blood reductions up to 69% and PMS1 mRNA up to 26%.

$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).